---
title: "DC 7723 - Acquired hemolytic anemia:"
diagnostic_code: "7723"
body_system: "Hemic and Lymphatic Systems"
cfr_section: "§ 4.117"
canonical: "https://veteranai.co/va-rating-schedule/hemic-and-lymphatic/7723-acquired-hemolytic-anemia"
source: "https://www.ecfr.gov/current/title-38/section-4.117"
updated: "2026-07-21T21:11:39.344359Z"
---

# DC 7723 - Acquired hemolytic anemia:

Rated under § 4.117. Body system: Hemic and Lymphatic Systems.

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | Requiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone, Cytoxan, azathioprine, or rituximab) |
| 60% | Requiring immunosuppressive medication 4 or more times per 12-month period |
| 30% | Requiring at least 2 but less than 4 courses of immunosuppressive therapy per 12-month period |
| 10% | Requiring one course of immunosuppressive therapy per 12-month period |
| 0% | Asymptomatic |

## Notes

- Note (1): A 100 percent evaluation for bone marrow transplant shall be assigned as of the date of hospital admission and shall continue for six months after hospital discharge with a mandatory VA examination six months following hospital discharge. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter
- Note (2): Separately evaluate splenectomy under diagnostic code 7706 and combine with an evaluation under diagnostic code 7723

# Acquired Hemolytic Anemia — VA Disability Rating Guide

**Diagnostic Code 7723 · 38 CFR § 4.117 · Hemic and Lymphatic Systems**

---

## What Is Acquired Hemolytic Anemia?

Acquired hemolytic anemia is a condition affecting the **hemic and lymphatic systems** (the body's blood and immune-related systems). The VA rates this condition under **Diagnostic Code 7723**, found in **38 CFR § 4.117**.

The rating you receive is based largely on the type and frequency of treatment your condition requires — from no active symptoms to ongoing therapy such as a bone marrow transplant or continuous medication.

---

## Available Rating Levels

The VA assigns a disability rating based on the following levels:

| Rating | What It Reflects |
|--------|------------------|
| **100%** | Requiring a bone marrow transplant, or continuous intravenous or immunosuppressive therapy (for example, prednisone, Cytoxan, azathioprine, or rituximab). |
| **60%** | Requiring immunosuppressive medication 4 or more times per 12-month period. |
| **30%** | Requiring at least 2 but less than 4 courses of immunosuppressive therapy per 12-month period. |
| **10%** | Requiring one course of immunosuppressive therapy per 12-month period. |
| **0%** | Asymptomatic (no active symptoms). |

---

## What the VA Looks For

When rating acquired hemolytic anemia, the VA focuses on the **treatment your condition requires** and, in many cases, **how often that treatment is needed over a 12-month period**. Key factors include:

- **Whether you require a bone marrow transplant** or continuous intravenous/immunosuppressive therapy.
- **The number of courses of immunosuppressive therapy** needed within a 12-month period.
- **Whether the condition is asymptomatic.**

### Important Notes

- **Note (1):** A 100 percent evaluation for a bone marrow transplant is assigned as of the date of hospital admission and continues for six months after hospital discharge, with a mandatory VA examination six months following hospital discharge. Any reduction in evaluation based on that or any subsequent examination is subject to the provisions of **§ 3.105(e)**.
- **Note (2):** A splenectomy is evaluated separately under **Diagnostic Code 7706** and combined with an evaluation under Diagnostic Code 7723.

---

*This information is drawn directly from the VA rating schedule under 38 CFR § 4.117, Diagnostic Code 7723. Individual ratings depend on your specific medical evidence and circumstances.*

Source: https://www.ecfr.gov/current/title-38/section-4.117